image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Murgitroyd - Patent attorney firm going great guns

October 2005

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • MUR
  • Price:
  • 204p
With patent translator RWS (230p) continuing to hit new highs following our recommendation last month, now seems a good time to look at Murgitroyd, the UK’s only quoted firm of patent and trade mark attorneys. Like RWS, Murgitroyd is benefiting from the long-term growth in the number of patents being filed in Europe and it too can boast a fantastic record, with sales nearly tripling from £5.1m in 1998 to £14.5m in 2005, while pretax profit has risen almost four-fold from £370,000 to £1.4m.  Murgitroyd specialises in the provision of intellectual property (IP) services for patents, trade marks and copyrights, which involves everything from drafting the legal documents to filing, assigning and mana ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X